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Atherosclerotic coronary heart disease remains the
leading cause of morbidity and mortality in popula-
tions with so-called western lifestyle. During the last
two decades intravascular ultrasound (IVUS) allowed
us to study the atherosclerotic disease process in the
coronary vessel wall in vivo [1–4]. By use of
motorized pullback systems, volumetric IVUS data
could be obtained that turned out to be ideal for such
studies [5–7]. As a result, our insights have been
extended from beyond what was known from histo-
pathology and angiographic studies. Serial studies
with grey-scale IVUS enriched our understanding of
the disease mechanisms involved (e.g., vascular
remodelling and progression–regression) and permit
an early estimation of the potential effectiveness of
new pharmacological anti-atherosclerotic concepts
[5, 8, 9].
Intravascular ultrasound assessment of clinically
highly successful pharmacological interventions
demonstrated some effects on plaque progression–
regression and on vascular remodelling; however,
these effects on plaque dimensions were relatively
small [8]. The discordance between signiﬁcant clin-
ical beneﬁt and only mild effects on plaque size could
be explained by an additional beneﬁcial effect on
plaque composition that may lead to stabilisation of
the atheroma. Conventional grey-scale IVUS is
limited in the assessment of plaque composition
[2, 10]. For that reason, a novel approach for
radiofrequency (RF)-based analysis of IVUS data
was developed which quantiﬁes coronary plaque
components and permits the detection of features of
plaque vulnerability (e.g., necrotic core and thin-cap
ﬁbro-atheroma) [10–13]. As recently demonstrated in
mild-to-moderately diseased coronary arterial seg-
ments in vivo, volumetric RF-based IVUS analysis
shows a relatively high measurement reproducibility
for both interobserver and between centre-compari-
sons [14, 15]. Despite some limitations, studies with
RF-based IVUS go beyond the scope of plaque size
measurement and may provide additional information
on the nature and the ‘‘pathology’’ of coronary
atherosclerosis.
Post-mortem studies of coronary arterial specimen
previously provided evidence that the necrotic core
size and relative necrotic core content of a plaque are
features of plaque instability that are related to
coronary events [16–18]. Because of the known
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plaque composition, conventional IVUS could only
be used to examine the size of the cavities inside
ulcerated ruptured plaques, which were considered to
reasonably correspond with the necrotic core volume
prior to plaque rupture [1, 3, 6].
In correspondence with grey-scale IVUS data of
our own group [1], the volumetric RF-based IVUS
data of Xu et al. [19] published in the present edition
of the International Journal of Cardiovascular
Imaging, show that the (absolute) volume of the
necrotic core was greater in larger plaques. Kaple
et al. [20] recently showed with RF-based IVUS in 90
de-novo coronary lesions that the site of the largest
necrotic core was more often proximal to the minimal
lumen site where vessel dimensions were larger.
They also demonstrated a relation between positive
vascular remodelling and greater size of necrotic core
[20]. Missel et al. [21] analyzed registry data of 225
patients with non-ST elevation acute coronary syn-
dromes to show that necrotic core volume was
signiﬁcantly larger in patients with elevated cardiac
enzymes; they found that the percentage of necrotic
core and its ratio to dense calcium were positively
associated with increased risk.
In the study by Xu et al. [19] volumetric RF-based
(Virtual Histology) IVUS of 224 target lesions
showed a signiﬁcant linear relation between plaque
volume and the absolute amount of tissue compo-
nents. To put it in other words: the greater the plaque,
the greater the volume of each plaque component
(e.g. necrotic core tissue). However, the authors
found no relation between overall plaque volume and
the relative content of necrotic core tissue. That is,
larger (more advanced) plaques did not show a
signiﬁcantly higher percentage of necrotic core [19],
which is consistent with registry data that were
recently published by Qian et al. [22].
But is plaque size all that matters for the
vulnerability and the necrotic core content of
coronary plaques? The data of some other studies
actually suggest a somewhat more loose relation
between plaque size and the actual amount of
necrotic core. The results of the serial multicenter,
randomized, placebo-controlled pharmacological
intervention trial Integrated Biomarker And Imaging
Study-2 (IBIS-2)—for instance—support this idea
[23]. The study assessed changes in volumetric
plaque composition as an endpoint to test the effect
of the inhibition of the enzyme lipoprotein-associ-
ated phospholipase-A2 with darapladib. The placebo
group was treated with maximum current therapies
(including intense statin therapy) and ﬁnally showed
non-signiﬁcant decrease in plaque volume but a
signiﬁcant increase in absolute and relative necrotic
core content; darapladib treatment, on the other
hand, stopped necrotic core increase [23]. While the
design of the IBIS-2 trial is serial, the observational
study by Xu et al. has a cross-sectional design
(assessment at one time); therefore, these ﬁndings
may not actually reﬂect plaque progression, which is
a dynamic process over time.
Several factors and mechanisms other than plaque
size could co-determine the relative extent of necrotic
core tissue; examples may be: acute coronary
syndromes; an increased ‘‘inﬂammatory status’’;
increased major cardiovascular risk factors such as
diabetes; and/or genetic factors. Xu et al. [19]
performed in their study some subgroup analyses
based on such clinical characteristics (patients with
and without acute coronary syndrome and diabetes
mellitus); but in these (partly rather small) subgroups,
ﬁndings were essentially similar to the overall
population. This is in contrast to the outcomes of
several other studies, which suggested a relatively
higher necrotic core content in patients with acute
coronary syndromes and with diabetes mellitus
[24–27].
The analysis of data from large serial IVUS
studies with RF-based assessment of plaque com-
position will be required to obtain further insight
into this interesting matter. Optical coherence
tomography (OCT), a light-based technique for
invasive coronary imaging, permits an even more
detailed assessment of coronary plaques at higher
resolution [28–30]. As OCT is limited in penetration
depth, IVUS and OCT may complement each other
[31, 32]. Therefore, the combined use of both
techniques in serial trials may signiﬁcantly advance
our knowledge of coronary atherosclerosis and its
progression.
There is obviously a strong relation between
plaque size and features of plaque vulnerability;
however, we would expect that future advanced
coronary imaging studies may reveal that the size of
the atherosclerotic plaque is not all that matters.
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